Lactococcus petauri LZys1 modulates gut microbiota, diminishes ileal FXR-FGF15 signaling, and regulates hepatic function
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.01716-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Ouyang Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Clinical Geriatric Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Fibroblast Growth Factors, Liver, Ileum. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Recent studies have indicated that Lactococcus petauri LZys1 ( L. petauri LZys1), isolated from healthy human feces, exhibits a promising probiotic profile in vitro . However, its impact on the physiological status of the host in vivo remains uncertain. The objective of our study was to investigate the effects and mechanisms of orally administering L. petauri LZys1 on gut microbiota and liver function in mice. We administered L. petauri LZys1 through daily oral gavage to C57BL/6 male mice. Subsequently, we analyzed changes in gut microbiota composition using 16S rRNA sequencing and quantified alterations in hepatic-intestinal bile acid (BA) profile. Serum biochemical parameters were assessed to evaluate liver function. Our findings revealed that L. petauri LZys1 led to an increase in body weight, liver mass, and serum aminotransferase levels. Oral administration altered the gut microbiota composition, resulting in reduced diversity and abundance of intestinal bacteria. Additionally, the profiles of BAs were suppressed across organs, associated with the downregulation of the ileum’s farnesoid X receptor (FXR)/fibroblast growth factor 15 (FGF15) signaling pathway. The decrease in circulating FGF15 mediated the downregulation of hepatic fibroblast growth factor receptor 4 (FGFR4)/FXR, disrupting BA metabolism and fatty acid oxidation. Our findings suggest that L. petauri LZys1 may impact liver function by influencing the gut microbiota-mediated ileal FXR–FGF15 axis and inhibiting hepatic bile acid metabolism. IMPORTANCE This work elucidated the impact of L. petauri LZys1 on host gut microbiota metabolism and hepatic physiological metabolism. We observed that L. petauri LZys1 administration induced liver weight gain and biochemical parameters changes, in addition to a altered gut microbiota and suppressed bile acid (BA) profiles. Furthermore, we propose that changes in liver status are related to the enterohepatic farnesoid X receptor–fibroblast growth factor axis, which alters bile acid metabolism and disrupts liver function. The above findings suggest that attention should be paid to the effect of probiotics on liver function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Key Laboratory of Clinical Geriatric Medicine, Shanghai, China.
- Digestive Endoscopy Center, Huadong Hospital, Fudan University, Shanghai, China.
- Department of Pathogenic Biology, Public Center of Experimental Technology of Pathogen Biology Technology Platform, Southwest Medical University, Luzhou, Sichuan, China.
- Department of Gerontology, Huadong Hospital, Fudan University, Shanghai, China.
ORCID-Profile: Ouyang Li, Zhijun Bao, Fan Yang
Zitieren
APA
Li, O., Zhou, Y., Kim, D., Xu, H., Bao, Z., & Yang, F. (2025). Lactococcus petauri LZys1 modulates gut microbiota, diminishes ileal FXR-FGF15 signaling, and regulates hepatic function. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01716-24
Vancouver
Li O, Zhou Y, Kim D, Xu H, Bao Z, Yang F. Lactococcus petauri LZys1 modulates gut microbiota, diminishes ileal FXR-FGF15 signaling, and regulates hepatic function. Microbiology Spectrum. 2025. doi:10.1128/spectrum.01716-24
BibTeX
@article{Li2025,
author = {Li, Ouyang and Zhou, Yingshun and Kim, Dayoung and Xu, Han and Bao, Zhijun and Yang, Fan},
title = {Lactococcus petauri LZys1 modulates gut microbiota, diminishes ileal FXR-FGF15 signaling, and regulates hepatic function},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.01716-24}
}
EUVIMED